v3.26.1
CONDENSED CONSOLIDATED STATEMENTS OF EQUITY - USD ($)
$ in Thousands
Total
Total Stockholders’ Equity
Common Stock
Additional Paid-in Capital
Accumulated Deficit
Accumulated Other Comprehensive Loss
Noncontrolling Interest
Beginning balance (in shares) at Dec. 31, 2024     340,258,453        
Beginning balance at Dec. 31, 2024 $ 4,135,942 $ 4,129,033 $ 34 $ 4,155,386 $ (26,387)   $ 6,909
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Stock-based compensation, net of tax withholding (in shares)     1,741,090        
Stock-based compensation, net of tax withholding 49,115 49,115   49,115      
Issuance of common stock, net of offering costs (in shares)     5,428,548        
Issuance of common stock, net of offering costs 100,140 100,140   100,140      
Issuance of non-controlling interest in subsidiary 11,795           11,795 [1]
Repurchase of shares in settlement of restricted stock (in shares)     (1,148,688)        
Repurchase of shares in settlement of restricted stock (20,362) (20,362)   (20,362)      
Distribution to noncontrolling interest (2,712)           (2,712)
Net loss (533,443) (533,199)     (533,199)   (244)
Ending balance (in shares) at Mar. 31, 2025     346,279,403        
Ending balance at Mar. 31, 2025 $ 3,728,680 3,724,727 $ 34 4,284,279 (559,586)   3,953
Beginning balance (in shares) at Dec. 31, 2025 379,464,892   379,464,892        
Beginning balance at Dec. 31, 2025 $ 3,477,090 3,471,720 $ 37 4,809,550 (1,337,867) $ 0 5,370 [1]
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Stock-based compensation, net of tax withholding (in shares)     2,284,731        
Stock-based compensation, net of tax withholding 31,873 31,873 $ 1 31,872      
Repurchase of shares in settlement of restricted stock (in shares)     (876,536)        
Repurchase of shares in settlement of restricted stock (7,455) (7,455)   (7,455)      
Distribution to noncontrolling interest (38)           (38) [1]
Foreign exchange loss on translation (4,544) (4,544)       (4,544)  
Net loss (1,260,498) (1,259,619)     (1,259,619)   (879) [1]
Net loss $ (1,262,397)            
Ending balance (in shares) at Mar. 31, 2026 380,873,087   380,873,087        
Ending balance at Mar. 31, 2026 $ 2,248,223 $ 2,231,975 $ 38 $ 4,833,967 $ (2,597,486) $ (4,544) $ 16,248 [1]
[1] Net loss attributable to noncontrolling interest for the three months ended March 31, 2026 excludes a $1.9 million net loss attributable to redeemable noncontrolling interest, which is presented separately. Refer to Note 2 – Summary of Significant Accounting Policies, “Redeemable Noncontrolling Interest,” for further information.